Aimmune Therapeutics (AIMT) is soaring to fall under $20 after deal with Nestle. Here is why

Drastically soaring stocks usually plummet quickly on the next day for selling bubble shares that are backed by euphoric news from IR departments. Aimmune (AIMT) could be very dangerous for happy buyers who may think of its bright future.

From $12.60 to $34.19 is obviously a change of bubble effect. The next day, AIMT may fall by at least 30% which is going to continue as other news will not back that price up.

Its negative EPS is a number one factor to pressure the share price as long term traders usually like stocks with positive earnings. Even till the market closes $34.19 may shrink to $28.00 perhaps.

Jack Dawkins

Finance and Tech Contributor